Zealand Pharma A/S

Headquarters: Copenhagen, Denmark

Employees: 355

CEO: Dr. Emmanuel Dulac Pharm.D., PharmD, Ph.D., MBA

OMXC: ZEAL -2.99%

Market Cap

kr.21.50 Billion

DKK as of Jan. 1, 2024

US$3.18 Billion

Market Cap History

Zealand Pharma A/S market capitalization over time

Evolution of Zealand Pharma A/S market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Zealand Pharma A/S

Detailed Description

Zealand Pharma A/S, a biotechnology company, engages in the discovery, design, and development of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. The company markets lixisenatide under the brand names of Adlyxin, Lyxumia, Soliqua 100/33, and Suliqua. Its product pipeline includes Dasiglucagon single use syringe or autoinjector that has completed Phase III clinical trials for the treatment of severe hypoglycemia; Dasiglucagon dual-hormone artificial pancreas has completed Phase II clinical trials for automated diabetes management; Dasiglucagon that is in Phase III clinical trials for congenital hyperinsulinism and in Phase II clinical trials for post bariatric surgery hypoglycemia. The company is also developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. Zealand Pharma A/S has collaboration agreements with Sanofi-Aventis Deutschland GmbH; Boehringer Ingelheim International GmbH; Alexion; and Beta Bionics, Inc. The company was founded in 1997 and is headquartered in Copenhagen, Denmark.

Top 1-year algo backtest: +269.94%

$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Stocks & Indices

Zealand Pharma A/S has the following listings and related stock indices.

Stock: OMXC: ZEAL wb_incandescent

Stock: NASDAQ: ZEAL wb_incandescent

Stock: FSX: 22ZA wb_incandescent

Stock: OTC: ZLDPF wb_incandescent

Stock: FSX: 22Z wb_incandescent



Sydmarken 11


Copenhagen, 2860


Phone: 45 88 77 36 00

Fax: 45 88 77 38 98